.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Citi
Cipla
Julphar
Covington
Deloitte
Cantor Fitzgerald
Express Scripts
Colorcon
Moodys

Generated: December 15, 2017

DrugPatentWatch Database Preview

BEROCCA PN Drug Profile

« Back to Dashboard

When do Berocca Pn patents expire, and what generic alternatives are available?

Berocca Pn is a drug marketed by Roche and is included in one NDA.

The generic ingredient in BEROCCA PN is ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin 5'-phosphate sodium; thiamine hydrochloride; vitamin a palmitate; vitamin e. There are six drug master file entries for this compound. Additional details are available on the ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin 5'-phosphate sodium; thiamine hydrochloride; vitamin a palmitate; vitamin e profile page.

Summary for BEROCCA PN

You have an error in your SQL syntax; check the manual that corresponds to your MariaDB server version for the right syntax to use near 'SODIUM','THIAMINE HYDROCHLORIDE','VITAMIN A PALMITATE','VITAMIN E') AND hsdb_dru' at line 1
US Patents:0
Applicants:1
NDAs:1